Published in Hippokratia on April 01, 2008
Association of glucose transporter 4 genetic polymorphisms with obstructive sleep apnea syndrome in Han Chinese general population: a cross-section study. Lipids Health Dis (2014) 0.76
Uncontrolled blood pressure and risk of sleep apnea among blacks: findings from the metabolic syndrome outcome (MetSO) study. J Hum Hypertens (2015) 0.75
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Banting lecture 1988. Role of insulin resistance in human disease. Diabetes (1988) 33.22
The metabolic syndrome--a new worldwide definition. Lancet (2005) 23.51
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation (2004) 20.67
Leptin and the regulation of body weight in mammals. Nature (1998) 14.84
Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet (1962) 13.72
Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med (2001) 12.29
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA (2000) 12.27
Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care (1991) 9.95
Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation (2000) 7.37
C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol (1999) 7.15
Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA (2003) 5.39
The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care (2003) 5.27
Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet (2002) 4.86
Excess weight and sleep-disordered breathing. J Appl Physiol (1985) (2005) 4.72
Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab (1997) 4.47
Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab (2000) 4.34
Pathophysiology of insulin resistance in human disease. Physiol Rev (1995) 3.95
Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J (2004) 3.77
Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ (2000) 3.60
Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia (1991) 3.48
Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med (2003) 3.42
Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med (1993) 3.02
Sleep apnea and hypertension. A population-based study. Ann Intern Med (1994) 2.79
Clinical practice. Obstructive sleep apnea. N Engl J Med (2002) 2.67
Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med (1989) 2.63
Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest (2002) 2.52
Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab (2004) 2.11
Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev (2005) 2.09
Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J (2004) 2.01
Obstructive sleep apnea syndrome and tracheostomy. Long-term follow-up experience. Arch Intern Med (1981) 1.79
Bradycardia during sleep apnea. Characteristics and mechanism. J Clin Invest (1982) 1.74
Obesity: epidemiology and clinical aspects. Best Pract Res Clin Gastroenterol (2004) 1.71
Sleep-induced apnea syndrome. Prevalence of cardiac arrhythmias and their reversal after tracheostomy. Am J Med (1977) 1.70
Plasma fibrinogen: a new factor of the metabolic syndrome. A population-based study. Diabetes Care (1998) 1.67
Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest (2007) 1.62
Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation (2002) 1.54
C-reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol (2003) 1.43
Obesity, sleep apnea, and hypertension. Hypertension (2003) 1.41
Sleepiness-related accidents in sleep apnea patients. Sleep (2000) 1.40
Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). Arterioscler Thromb Vasc Biol (1999) 1.37
Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care (1999) 1.36
Extreme obesity associated with alveolar hypoventilation--a Pickwickian Syndrome. 1956. Obes Res (1994) 1.23
"Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease. Thorax (1998) 1.22
Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med (2007) 1.21
Blood pressure and sleep apnea: results of long-term nasal continuous positive airway pressure therapy. Cardiology (1991) 1.19
Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications (2000) 1.18
Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis (1990) 1.17
Cardiac arrhythmias and conduction disturbances in the sleep apnea syndrome. Prevalence and significance. Am J Med (1982) 1.13
The dysmetabolic syndrome. J Intern Med (2001) 1.08
Electrophysiologic evaluation of sinus node function and atrioventricular conduction in patients with prolonged ventricular asystole during obstructive sleep apnea. Am J Cardiol (1996) 1.05
Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure. Am J Respir Crit Care Med (1995) 1.03
The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. Metabolism (1993) 1.02
Staging of heavy snorers' disease. A proposal. Bull Eur Physiopathol Respir (1984) 1.01
Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir J (2004) 0.95
Sleep disordered breathing--a new component of syndrome x? Obes Rev (2001) 0.93
Interactions between obstructive sleep apnea and the metabolic syndrome. Curr Diab Rep (2005) 0.92
Obstructive sleep apnoea, metabolic syndrome, and cardiovascular outcomes. Eur Heart J (2004) 0.91
A waist is a terrible thing to mind: central obesity, the metabolic syndrome, and sleep apnea hypopnea syndrome. Chest (2002) 0.90
Neuroendocrine changes in sleep apnea. Curr Opin Pulm Med (2004) 0.81
Sleep apnea and hypertension: pathophysiologic mechanisms. Semin Nephrol (2002) 0.79
Nocturnal hemodynamics in patients with sleep apnea. Eur J Respir Dis Suppl (1986) 0.76
Hereditary C1q deficiency and systemic lupus erythematosus. QJM (1994) 1.47
Overrepresentation of the Fcgamma receptor type IIA R131/R131 genotype in caucasoid systemic lupus erythematosus patients with autoantibodies to C1q and glomerulonephritis. Arthritis Rheum (1999) 1.05
Hereditary complement factor I deficiency. QJM (1994) 1.02
Neurohypophysial hormone and melatonin secretion over the natural and suppressed menstrual cycle in premenopausal women. Clin Endocrinol (Oxf) (1998) 0.98
Sex hormones in postmenopausal women with breast cancer on tamoxifen. Horm Res (1997) 0.82
Factor V Leiden mutation and venous thrombosis. Lancet (1995) 0.81
Clearance pathways of soluble immune complexes in the pig. Insights into the adaptive nature of antigen clearance in humans. J Immunol (1995) 0.79
Mixed medullary-follicular thyroid carcinoma. Report of a case and review of the literature. Horm Res (2004) 0.79
Relapsing Wegener's granulomatosis: successful treatment with cyclosporin-A. Clin Rheumatol (1996) 0.76
The anti-lipid A monoclonal antibody E5 binds to rough gram-negative bacteria, fixes C3, and facilitates binding of bacterial immune complexes to both erythrocytes and monocytes. Immunology (1995) 0.75
Thyroid function in postmenopausal women with breast cancer on tamoxifen. Eur J Gynaecol Oncol (1998) 0.75